BRIM Biotechnology, Inc. (TPE:6885)
Taiwan · Delayed Price · Currency is TWD 27.70
-0.30 (-1.07%)
At close: Jan 21, 2026
BRIM Biotechnology Market Cap
BRIM Biotechnology has a market cap or net worth of 3.69 billion as of January 21, 2026. Its market cap has decreased by -12.26% in one year.
Market Cap
3.69B
Enterprise Value
2.50B
Revenue
3.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.70
Market Cap Chart
Since June 23, 2022, BRIM Biotechnology's market cap has increased from 1.77B to 3.69B, an increase of 108.95%. That is a compound annual growth rate of 22.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 3.69B | -6.89% |
| Dec 31, 2025 | 3.96B | -2.58% |
| Dec 31, 2024 | 4.07B | 17.34% |
| Dec 29, 2023 | 3.47B | -2.55% |
| Dec 30, 2022 | 3.56B | 101.45% |
| Jun 23, 2022 | 1.77B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 263.50B |
| PharmaEssentia | 217.10B |
| Lotus Pharmaceutical | 88.76B |
| Bora Pharmaceuticals Co., LTD. | 67.84B |
| Heron Neutron Medical | 67.13B |
| Oneness Biotech | 33.73B |
| Center Laboratories | 31.50B |
| Lumosa Therapeutics | 31.25B |